SEC Company Response from InflaRx N.V. (IFRX) (CIK 0001708688) (IFRX) — Jul 16, 2020
InflaRx N.V. (IFRX) (CIK 0001708688)
Date: July 16, 2020 · CIK: 0001708688 · Accession: 0001140361-20-016136
AI Filing Summary & Sentiment
File numbers found in text: 333-239759
Show Raw Text
CORRESP
1
filename1.htm
InflaRx N.V.
Winzerlaer Str. 2
07745 Jena, Germany
July 16, 2020
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Re:
InflaRx N.V.
Registration Statement on Form F-3
Filing Date July 8, 2020
File No. 333-239759
REQUEST FOR ACCELERATION OF EFFECTIVENESS
Pursuant to Rule 461 under the Securities Act of 1933, as amended, InflaRx N.V. (the “Company”) hereby requests acceleration of the effective
date of its Registration Statement on Form F-3 (the “Registration Statement”), File No. 333-239759, to 4:30 p.m., Eastern Time, on July 17, 2020, or as soon thereafter as practicable.
Please contact Sophia Hudson of Kirkland & Ellis LLP, counsel to the Company, at (212) 446-4750 as soon as the Registration Statement has been declared
effective, or if you have any other questions or concerns regarding this matter.
Sincerely,
/s/ Niels Riedemann
Niels Riedemann
Chief Executive Officer